CERC TEST FINDS ASPIRIN BRANDS SUBSTANDARD

Article Abstract:

As per the findings of the Consumer Education Research Centre (CERC), all tablets of Aspirin available in India are not effective. The test was conducted on two types of aspirin - soluble and plain. It was found that soluble Aspirin, Dispirin and Colspirin brands met the Indian Pharmacopoenia (IP) standards and the plain aspirin of Indigenous Drug Pharmaceuticals, CPL Enterprise, Debonair Pharmaceuticals and Manish Pharma Lab failed to meet the IP standards. (gsh)

Product information, Aspirin

---

NPPA REVISES RIFAMPICIN PRICES

Article Abstract:

The National Pharmaceutical Pricing Authority (NPPA) has increased the prices of anti-tuberculosis bulk drug rifampicin to Rs4,885 per kg from Rs4,807 per kg. The move will benefit the formulators who use the bulk drug to manufacture finished dosage forms. They will get higher prices for these drugs as per the government's pricing structure. (gs) (khr)

Pharmaceutical preparations, Consumer prices, Tuberculostatic Preparations, Antitubercular agents

---

Similar abstracts:

• Abstracts: UNFAIR VANTAGE IN UREA TAMIL NADU SUGAR MILLS TRY TO CARTELISE PRICES. SLIPPERY WHEN WET
• Abstracts: CIBA CALLS OFF TALKS FOR M-SEAL BRAND WITH MAHINDRAS. CIBATUL, ATUL LTD MERGER MOVES BEGIN NEXT WEEK
• Abstracts: NESTLE INDIA's NEW CHIEF PLAYS THE FLAGSHIP BRAND CARD MULTI-LEVEL DAZZLE. HLL's NIMBU SHAKTI TAKES ASCI BLOW
• Abstracts: CONCEPT FOODS TAKES ON HALLS, VICKS WITH TURMINT. DAPHNE DEVELOPS SOFTWARE FOR DATA WAREHOUSING. PURER STILL
• Abstracts: KHAITANS SELL NESTLE STAKE IN OPEN MARKET FOR Rs15 CR GODREJ-AGROVET LAUNCHES `6 WEEK CHICKEN'

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.